Changeflow GovPing Healthcare Citizen Petition to FDA by Kaylin Bower
Routine Notice Added Draft

Citizen Petition to FDA by Kaylin Bower

Favicon for www.regulations.gov Regs.gov: Food and Drug Administration
Published
Detected
Email

Summary

A citizen petition was filed with the FDA's Center for Drug Evaluation and Research (CDER) by Kaylin Bower on April 15, 2026. The petition docket is FDA-2026-P-4104-0001. The full contents of the petition are redacted due to personally identifiable information protections, limiting visibility into the specific regulatory relief requested.

What changed

A citizen petition was submitted to the FDA on April 15, 2026, by Kaylin Bower through CDER. The petition is currently in draft status, pending FDA review and response. Due to personal information protections, the substantive content of the petition is not publicly available.

Affected parties should monitor the docket for any FDA response or request for additional information. The petition may request regulatory changes, waivers, or other relief related to pharmaceutical products or drug approval processes under CDER jurisdiction.

What to do next

  1. Monitor FDA for petition response
  2. Review petition if contents become available

Archived snapshot

Apr 15, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Content

There are no documents available to view or download

Attachments 2

Citizen Petition from Kaylin Bower

Restricted: Personally Identifiable Information

More Information
- Author(s) CDER

Citizen Petition from Kaylin Bower_Redacted

More Information
- Author(s) CDER
Download

Get daily alerts for Regs.gov: Food and Drug Administration

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from FDA.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
FDA
Published
April 15th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Draft
Change scope
Minor
Document ID
FDA-2026-P-4104-0001
Docket
FDA-2026-P-4104-0001

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Regulatory petition filing Drug review request
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Healthcare Intellectual Property

Get alerts for this source

We'll email you when Regs.gov: Food and Drug Administration publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!